Log In
Print this Print this

FRM-0334 (formerly EVP-0334)

  Manage Alerts
Collapse Summary General Information
Company Forum Pharmaceuticals Inc.
DescriptionSmall molecule histone deacetylase (HDAC) inhibitor
Molecular Target Histone deacetylase (HDAC)
Mechanism of ActionHistone deacetylase (HDAC) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationFrontotemporal dementia
Indication DetailsTreat frontotemporal dementia (FTD) with granulin mutation
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today